BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38042497)

  • 41. Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study.
    Aso S; Navarro-Martin A; Castillo R; Padrones S; Castillo E; Montes A; Martínez JI; Cubero N; López R; Rodríguez L; Palmero R; Manresa F; Guerrero T; Molina M
    Radiat Oncol; 2020 Oct; 15(1):246. PubMed ID: 33109238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
    Hope AJ; Lindsay PE; El Naqa I; Alaly JR; Vicic M; Bradley JD; Deasy JO
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):112-24. PubMed ID: 16618575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.
    Wang H; Liao Z; Zhuang Y; Xu T; Nguyen QN; Levy LB; O'Reilly M; Gold KA; Gomez DR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1071-7. PubMed ID: 24161424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.
    Kimura T; Doi Y; Nakashima T; Imano N; Kawabata H; Nishibuchi I; Okabe T; Kenjo M; Ozawa S; Murakami Y; Nagata Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):778-87. PubMed ID: 26530746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve.
    Wang D; Shi J; Liang S; Lu S; Qi X; Wang Q; Zheng G; Wang S; Zhang K; Liu H
    Clin Transl Oncol; 2013 May; 15(5):364-9. PubMed ID: 22975900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
    Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
    Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio.
    Ueyama T; Arimura T; Takumi K; Nakamura F; Higashi R; Ito S; Fukukura Y; Umanodan T; Nakajo M; Koriyama C; Yoshiura T
    Br J Radiol; 2018 Jun; 91(1086):20170453. PubMed ID: 29565649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Outcomes and Predictors of Lung Toxicity After Multiple Courses of Lung Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
    Muller DA; Dutta SW; Aliotta E; Sanders JC; Wijesooriya K; Watkins WT; Larner JM
    Clin Lung Cancer; 2021 May; 22(3):234-241. PubMed ID: 32690439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
    Willner J; Jost A; Baier K; Flentje M
    Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
    Li F; Zhou Z; Wu A; Cai Y; Wu H; Chen M; Liang S
    Radiat Oncol; 2018 May; 13(1):82. PubMed ID: 29716649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.
    Wijsman R; Dankers FJWM; Troost EGC; Hoffmann AL; van der Heijden EHFM; de Geus-Oei LF; Bussink J
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):434-441. PubMed ID: 28871994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort.
    Tucker SL; Liao Z; Dinh J; Bian SX; Mohan R; Martel MK; Grosshans DR
    Acta Oncol; 2014 May; 53(5):590-6. PubMed ID: 23992110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning.
    Luna JM; Chao HH; Diffenderfer ES; Valdes G; Chinniah C; Ma G; Cengel KA; Solberg TD; Berman AT; Simone CB
    Radiother Oncol; 2019 Apr; 133():106-112. PubMed ID: 30935565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer.
    Uno T; Isobe K; Kawakami H; Ueno N; Kawata T; Yamamoto S; Sekine Y; Iyoda A; Iizasa T; Fujisawa T; Shigematsu N; Ito H
    Int J Clin Oncol; 2006 Feb; 11(1):55-9. PubMed ID: 16508730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inclusion of functional information from perfusion SPECT improves predictive value of dose-volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: A prospective study.
    Farr KP; Kallehauge JF; Møller DS; Khalil AA; Kramer S; Bluhme H; Morsing A; Grau C
    Radiother Oncol; 2015 Oct; 117(1):9-16. PubMed ID: 26303012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy.
    Zhou Z; Song X; Wu A; Liu H; Wu H; Wu Q; Liu Y; Li Y; Cai Y; Liang S
    Sci Rep; 2017 Jun; 7(1):2748. PubMed ID: 28584268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation Therapy.
    Shepherd AF; Iocolano M; Leeman J; Imber BS; Wild AT; Offin M; Chaft JE; Huang J; Rimner A; Wu AJ; Gelblum DY; Shaverdian N; Simone CB; Gomez DR; Yorke ED; Jackson A
    Pract Radiat Oncol; 2021; 11(1):e52-e62. PubMed ID: 33068790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.